Table 2.
MIC and MBC of isolated actinomycins X2 and D.
| Test organisms | MIC (µg/ml) | MBC (µg/ml) | Levofloxacin (5 µg/ml) | ||
|---|---|---|---|---|---|
| Actinomycin X2 | Actinomycin D | Actinomycin X2 | Actinomycin D | ||
| Non-MRSA bacteria | |||||
| S.aureus ATCC 29213 | 1.56 | 6.25 | 6.25 | 25 | Inhibition |
| S.saptophyticus ATCC 43867 | 3.125 | 12.5 | 12.5 | 50 | Inhibition |
| S.epidermidis ATCC 12228 | 1.56 | 6.25 | 6.25 | 25 | Inhibition |
| S.pyogenes-A ATCC 27736 | 12.5 | 12.5 | 25 | 50 | Inhibition |
| S.pneumoniae ATCC 49619 | 12.5 | 12.5 | 25 | 50 | Inhibition |
| E.faecalis ATCC 29212 | 12.5 | 12.5 | 50 | 50 | Inhibition |
| B.cereus ATCC 10876 | 1.56 | 3.125 | 12.5 | 25 | Inhibition |
| MRSA bacteria* | |||||
| MRSA-A | 3.125 | 25 | 12.5 | 50 | Inhibition |
| MRSA-B | 12.5 | 25 | 50 | 50 | Inhibition |
| MRSA-C | 3.125 | 12.5 | 12.5 | 50 | Inhibition |
*Clinical isolates.